Depleted Tumor Suppressor miR-655 in Plasma Contributes to Poor Outcomes and Is a Novel Therapeutic Target in Esophageal Squamous Cell Carcinoma
2017 ◽
Vol 225
(4)
◽
pp. S189
2013 ◽
Vol 43
(5)
◽
pp. 1523-1530
◽
2017 ◽
Vol 9
(6)
◽
pp. 1446-1449
◽
2016 ◽
Vol 83
◽
pp. 843-849
◽
2016 ◽
Vol 138
(12)
◽
pp. 2940-2951
◽
2019 ◽
Vol 11
(7)
◽
pp. 3015-3029
◽